Evidence map›Paper›PMID 9050901›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1997

Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac).

J García-Colunga, J N Awad, R Miledi

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 148 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Precision Medicine in Antidepressants Treatment.Handbook of experimental pharmacology · 2023
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Essential Contributions of Serotonin Transporter Inhibition to the Acute and Chronic Actions of Fluoxetine and Citalopram in the SERT Met172 Mouse.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2016
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Cytisine-based nicotinic partial agonists as novel antidepressant compounds.The Journal of pharmacology and experimental therapeutics · 2009
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

J García-ColungaDepartment of Psychobiology, University of California, Irvine 92697-4550, USA.
J N Awad
R Miledi
University of California, Irvine · US

Funding

STUDIES ON SEROTONIN RECEPTORS AND CHLORIDE CHANNELSR01NS023284 · NINDS · UNIVERSITY OF CALIFORNIA IRVINE · PI MILEDI, RICARDO MILEDI · 1986 to 1995
–
NINDS NIH HHS NS23284
6 · The paper itself

Abstract

Fluoxetine (Prozac), a widely used antidepressant, is said to exert its medicinal effects almost exclusively by blocking the serotonin uptake systems. The present study shows that both muscle and neuronal nicotinic acetylcholine receptors are blocked, in a noncompetitive and voltage-dependent way, by fluoxetine, which also increases the rate of desensitization of the nicotinic receptors. Because these receptors are very widely distributed in the both central and peripheral nervous systems, the blocking action of fluoxetine on nicotinic receptors may play an important role in its antidepressant and other therapeutical effects. Our findings will help to understand the mode of action of fluoxetine, and they may also help to develop more specific medicinal drugs.

Indexed as

AcetylcholineAnimalsAntidepressive Agents, Second-GenerationFluoxetineIon ChannelsMembrane PotentialsMiceMusclesNeuronsOocytesPatch-Clamp TechniquesRatsReceptors, NicotinicRNA, MessengerSerotoninXenopusAcetylcholineAntidepressive Agents, Second-GenerationFluoxetineIon ChannelsReceptors, NicotinicRNA, MessengerSerotonin

Identifiers

PMID9050901
PMCPMC20039
OpenAlexW2005233160

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.